| Heading: |
Children: Medical Treatments |
| Question ID: |
1744724 |
| UIN: |
16134 |
| House: |
Commons |
| Date tabled: |
2024-11-26 |
| Asking Member ID: |
4008 |
| Asking Member display name: |
Dame Caroline Dinenage
|
| Asking Member handle: |
cj_dinenage
|
| Asking Member Twitter reference: |
@cj_dinenage
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve treatment pathways for (a) PANS and (b) PANDAS patients. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-03 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department recognises the importance of raising awareness of rare diseases such as paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) among hea... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |